TickerFacts.

Edgewise Therapeutics, Inc. (EWTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

102.93M
Year ended 2025-12-31
+24.3%
3-year compound annual growth
2020-12-31: 739.0K2021-12-31: 37.53M2022-12-31: 53.59M2023-12-31: 63.72M2024-12-31: 92.41M2025-12-31: 102.93M102.93M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31102.93M+11.4%2026-02-26, From 2025-01-01
2024-12-3192.41M+45.0%2026-02-26, From 2024-01-01
2023-12-3163.72M+18.9%2026-02-26, From 2023-01-01
2022-12-3153.59Mn/c2024-02-22, From 2022-01-01
2021-12-3137.53Mn/m2023-02-23, From 2021-01-01
2020-12-31739.0Kn/a2022-02-24, From 2020-01-01